Concepts (213)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptors, Fc | 2 | 2011 | 32 | 0.570 |
Why?
|
| Prosencephalon | 1 | 2015 | 63 | 0.500 |
Why?
|
| Immunoglobulin G | 4 | 2008 | 465 | 0.490 |
Why?
|
| Vocalization, Animal | 1 | 2015 | 102 | 0.470 |
Why?
|
| Botulism | 1 | 2011 | 6 | 0.390 |
Why?
|
| Bacterial Vaccines | 1 | 2011 | 42 | 0.380 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2015 | 661 | 0.380 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2011 | 50 | 0.370 |
Why?
|
| Antigen-Presenting Cells | 1 | 2011 | 141 | 0.360 |
Why?
|
| Receptors, IgG | 2 | 2007 | 53 | 0.330 |
Why?
|
| Antigens | 2 | 2007 | 229 | 0.330 |
Why?
|
| Neurons | 2 | 2015 | 1584 | 0.330 |
Why?
|
| Adjuvants, Immunologic | 2 | 2007 | 168 | 0.310 |
Why?
|
| Serum Albumin | 1 | 2007 | 127 | 0.280 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 1997 | 9 | 0.250 |
Why?
|
| Recombinant Fusion Proteins | 2 | 2011 | 565 | 0.250 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 216 | 0.230 |
Why?
|
| Spodoptera | 3 | 2011 | 32 | 0.220 |
Why?
|
| Animals, Newborn | 3 | 2015 | 524 | 0.150 |
Why?
|
| Beta-Globulins | 1 | 1997 | 4 | 0.150 |
Why?
|
| Pharynx | 1 | 2017 | 45 | 0.150 |
Why?
|
| Inhalation | 1 | 2017 | 31 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2010 | 699 | 0.130 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2016 | 52 | 0.130 |
Why?
|
| Foster Home Care | 1 | 2015 | 3 | 0.130 |
Why?
|
| Analysis of Variance | 2 | 2015 | 899 | 0.130 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 2 | 2009 | 58 | 0.130 |
Why?
|
| Genetic Vectors | 2 | 2011 | 446 | 0.130 |
Why?
|
| Interferon-beta | 2 | 2009 | 126 | 0.130 |
Why?
|
| Thyroid Hormones | 1 | 1997 | 329 | 0.120 |
Why?
|
| Animals | 11 | 2015 | 27371 | 0.120 |
Why?
|
| Songbirds | 1 | 2015 | 84 | 0.120 |
Why?
|
| Immediate-Early Proteins | 1 | 2015 | 165 | 0.120 |
Why?
|
| Promoter Regions, Genetic | 1 | 1997 | 956 | 0.110 |
Why?
|
| Cold Temperature | 2 | 2010 | 160 | 0.110 |
Why?
|
| Tissue Culture Techniques | 2 | 2010 | 81 | 0.110 |
Why?
|
| Neural Pathways | 1 | 2015 | 319 | 0.110 |
Why?
|
| Isomerases | 1 | 1992 | 9 | 0.110 |
Why?
|
| Feeding Behavior | 1 | 2015 | 327 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 9 | 1 | 1992 | 86 | 0.100 |
Why?
|
| RNA, Messenger | 3 | 2015 | 2017 | 0.100 |
Why?
|
| Isoenzymes | 1 | 1992 | 274 | 0.100 |
Why?
|
| Microglia | 2 | 2010 | 107 | 0.100 |
Why?
|
| Neuroprotective Agents | 2 | 2010 | 100 | 0.100 |
Why?
|
| Antitoxins | 1 | 2011 | 2 | 0.100 |
Why?
|
| Baculoviridae | 1 | 2011 | 34 | 0.100 |
Why?
|
| Vaccines, Synthetic | 1 | 2011 | 55 | 0.090 |
Why?
|
| Vaccines, Subunit | 1 | 2011 | 55 | 0.090 |
Why?
|
| Interleukin-11 | 1 | 2010 | 20 | 0.090 |
Why?
|
| Antibodies, Bacterial | 1 | 2011 | 100 | 0.090 |
Why?
|
| Age Factors | 1 | 2015 | 1870 | 0.090 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 1976 | 0.090 |
Why?
|
| Antibodies, Neutralizing | 1 | 2011 | 120 | 0.090 |
Why?
|
| Hippocampus | 2 | 2010 | 447 | 0.090 |
Why?
|
| Antibodies | 2 | 2010 | 353 | 0.080 |
Why?
|
| Mice, Inbred BALB C | 1 | 2011 | 1088 | 0.080 |
Why?
|
| Monocytes | 1 | 2009 | 218 | 0.080 |
Why?
|
| Mice | 4 | 2011 | 11761 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2009 | 289 | 0.080 |
Why?
|
| Endocytosis | 1 | 2008 | 180 | 0.070 |
Why?
|
| Trisaccharides | 1 | 2007 | 12 | 0.070 |
Why?
|
| U937 Cells | 1 | 2007 | 32 | 0.070 |
Why?
|
| Cells, Cultured | 5 | 2008 | 2884 | 0.070 |
Why?
|
| Cell Line | 1 | 2011 | 2496 | 0.070 |
Why?
|
| Transplantation, Heterologous | 1 | 2007 | 370 | 0.060 |
Why?
|
| Ligands | 1 | 2007 | 445 | 0.060 |
Why?
|
| Lipocalins | 2 | 1997 | 35 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2007 | 463 | 0.060 |
Why?
|
| Disulfiram | 1 | 2004 | 8 | 0.060 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2007 | 242 | 0.060 |
Why?
|
| Metals | 1 | 2004 | 93 | 0.060 |
Why?
|
| Cell Line, Tumor | 2 | 2007 | 2558 | 0.060 |
Why?
|
| T-Lymphocytes | 1 | 2009 | 1224 | 0.050 |
Why?
|
| Brain | 1 | 1992 | 2285 | 0.050 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2007 | 560 | 0.050 |
Why?
|
| Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase | 1 | 2001 | 7 | 0.050 |
Why?
|
| Binding Sites, Antibody | 1 | 2001 | 49 | 0.050 |
Why?
|
| Base Sequence | 2 | 1997 | 2327 | 0.050 |
Why?
|
| Etretinate | 1 | 2001 | 4 | 0.050 |
Why?
|
| Antibody Affinity | 1 | 2001 | 38 | 0.050 |
Why?
|
| Multiple Sclerosis, Chronic Progressive | 1 | 2001 | 8 | 0.050 |
Why?
|
| Molecular Weight | 1 | 2001 | 331 | 0.050 |
Why?
|
| Dimerization | 1 | 2001 | 143 | 0.050 |
Why?
|
| Glycosylation | 1 | 2001 | 128 | 0.050 |
Why?
|
| Rats | 4 | 2010 | 4041 | 0.050 |
Why?
|
| Interleukin-12 | 1 | 2001 | 109 | 0.050 |
Why?
|
| Molecular Sequence Data | 2 | 1997 | 3027 | 0.040 |
Why?
|
| Melanoma | 1 | 2004 | 468 | 0.040 |
Why?
|
| Phosphopyruvate Hydratase | 2 | 2010 | 41 | 0.040 |
Why?
|
| Protein Engineering | 1 | 2001 | 141 | 0.040 |
Why?
|
| N-Methylaspartate | 2 | 2010 | 51 | 0.040 |
Why?
|
| Humans | 10 | 2017 | 89357 | 0.040 |
Why?
|
| Blotting, Western | 1 | 2001 | 794 | 0.040 |
Why?
|
| Female | 6 | 2017 | 46202 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 740 | 0.040 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2001 | 306 | 0.040 |
Why?
|
| Maximal Respiratory Pressures | 1 | 2017 | 1 | 0.040 |
Why?
|
| Inspiratory Capacity | 1 | 2017 | 2 | 0.040 |
Why?
|
| Palate | 1 | 2017 | 6 | 0.040 |
Why?
|
| Epiglottis | 1 | 2017 | 6 | 0.040 |
Why?
|
| Airway Resistance | 1 | 2017 | 70 | 0.040 |
Why?
|
| Tongue | 1 | 2017 | 57 | 0.040 |
Why?
|
| Intention to Treat Analysis | 1 | 2016 | 69 | 0.030 |
Why?
|
| Cytokines | 2 | 2010 | 803 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2004 | 1653 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 1997 | 646 | 0.030 |
Why?
|
| Blotting, Northern | 2 | 1993 | 258 | 0.030 |
Why?
|
| Gene Deletion | 1 | 1997 | 342 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 161 | 0.030 |
Why?
|
| Cerebrovascular Disorders | 1 | 2016 | 145 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 1997 | 1057 | 0.030 |
Why?
|
| Middle Aged | 5 | 2017 | 25974 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2001 | 1412 | 0.030 |
Why?
|
| Oxyhemoglobins | 1 | 1993 | 30 | 0.030 |
Why?
|
| Endothelins | 1 | 1993 | 26 | 0.030 |
Why?
|
| TATA Box | 1 | 1992 | 11 | 0.030 |
Why?
|
| Lactoglobulins | 1 | 1992 | 8 | 0.030 |
Why?
|
| Antineoplastic Agents | 1 | 2004 | 2415 | 0.030 |
Why?
|
| Chromosome Banding | 1 | 1992 | 74 | 0.030 |
Why?
|
| Blotting, Southern | 1 | 1992 | 129 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1992 | 127 | 0.030 |
Why?
|
| Sheep | 1 | 1992 | 251 | 0.030 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 1993 | 241 | 0.030 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 1992 | 418 | 0.020 |
Why?
|
| RNA | 2 | 1993 | 580 | 0.020 |
Why?
|
| Male | 5 | 2017 | 42411 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2016 | 362 | 0.020 |
Why?
|
| Fetus | 1 | 1992 | 232 | 0.020 |
Why?
|
| Endothelium, Vascular | 1 | 1993 | 433 | 0.020 |
Why?
|
| Spinal Cord | 1 | 1992 | 255 | 0.020 |
Why?
|
| Cell Proliferation | 2 | 2009 | 1652 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 21 | 0.020 |
Why?
|
| Exons | 1 | 1992 | 451 | 0.020 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2010 | 45 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2010 | 43 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 59 | 0.020 |
Why?
|
| Organic Chemicals | 1 | 2010 | 34 | 0.020 |
Why?
|
| Hospitalization | 1 | 2016 | 877 | 0.020 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2010 | 24 | 0.020 |
Why?
|
| Glatiramer Acetate | 1 | 2009 | 14 | 0.020 |
Why?
|
| Interferon beta-1b | 1 | 2009 | 39 | 0.020 |
Why?
|
| B7-2 Antigen | 1 | 2009 | 40 | 0.020 |
Why?
|
| Time Factors | 2 | 2010 | 5338 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2016 | 711 | 0.020 |
Why?
|
| B7-1 Antigen | 1 | 2009 | 76 | 0.020 |
Why?
|
| Signal Transduction | 2 | 2010 | 3385 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1992 | 1076 | 0.020 |
Why?
|
| Cell Separation | 1 | 2009 | 198 | 0.020 |
Why?
|
| Temperature | 1 | 2010 | 404 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2009 | 323 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 2009 | 135 | 0.020 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2008 | 5 | 0.020 |
Why?
|
| Ectodysplasins | 1 | 2008 | 5 | 0.020 |
Why?
|
| Minocycline | 1 | 2008 | 15 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2008 | 1942 | 0.020 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2008 | 26 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2062 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2008 | 70 | 0.020 |
Why?
|
| Neurotoxins | 1 | 2008 | 49 | 0.020 |
Why?
|
| Interleukin-1beta | 1 | 2008 | 82 | 0.020 |
Why?
|
| Organ Culture Techniques | 1 | 2008 | 135 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2009 | 691 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2016 | 8241 | 0.020 |
Why?
|
| Membrane Glycoproteins | 1 | 2009 | 432 | 0.020 |
Why?
|
| Sertoli Cells | 1 | 2007 | 18 | 0.020 |
Why?
|
| Hemagglutinins | 1 | 2007 | 19 | 0.020 |
Why?
|
| Proteins | 1 | 1992 | 787 | 0.020 |
Why?
|
| Adult | 3 | 2017 | 26607 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2009 | 751 | 0.020 |
Why?
|
| Coculture Techniques | 1 | 2007 | 174 | 0.020 |
Why?
|
| DNA | 1 | 1992 | 1308 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2009 | 445 | 0.020 |
Why?
|
| Recurrence | 1 | 2009 | 1144 | 0.020 |
Why?
|
| Peptides | 1 | 2009 | 648 | 0.020 |
Why?
|
| Glucose | 1 | 2008 | 630 | 0.020 |
Why?
|
| Swine | 1 | 2007 | 582 | 0.020 |
Why?
|
| Cyclin A | 1 | 2004 | 29 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 2004 | 27 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2004 | 73 | 0.020 |
Why?
|
| Immunosuppressive Agents | 1 | 2009 | 975 | 0.010 |
Why?
|
| Cell Survival | 1 | 2007 | 983 | 0.010 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2004 | 68 | 0.010 |
Why?
|
| Response Elements | 1 | 2004 | 65 | 0.010 |
Why?
|
| Glutathione | 1 | 2004 | 108 | 0.010 |
Why?
|
| Copper | 1 | 2004 | 78 | 0.010 |
Why?
|
| Zinc | 1 | 2004 | 93 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2004 | 261 | 0.010 |
Why?
|
| Islets of Langerhans | 1 | 2007 | 549 | 0.010 |
Why?
|
| Hypoxia | 1 | 2008 | 653 | 0.010 |
Why?
|
| Graft Survival | 1 | 2007 | 900 | 0.010 |
Why?
|
| Biopsy | 1 | 2007 | 1184 | 0.010 |
Why?
|
| Neoplasms, Experimental | 1 | 2004 | 269 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 519 | 0.010 |
Why?
|
| Neovascularization, Pathologic | 1 | 2004 | 364 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2001 | 306 | 0.010 |
Why?
|
| Triglycerides | 1 | 2001 | 232 | 0.010 |
Why?
|
| Disability Evaluation | 1 | 2001 | 140 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2007 | 3666 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 19165 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2001 | 505 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 2004 | 758 | 0.010 |
Why?
|
| Skin | 1 | 2001 | 582 | 0.010 |
Why?
|
| Methemoglobin | 1 | 1993 | 8 | 0.010 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1993 | 13 | 0.010 |
Why?
|
| Adolescent | 1 | 2007 | 9263 | 0.010 |
Why?
|
| Staurosporine | 1 | 1993 | 33 | 0.010 |
Why?
|
| Alkaloids | 1 | 1993 | 46 | 0.010 |
Why?
|
| Colforsin | 1 | 1993 | 74 | 0.010 |
Why?
|
| Thrombin | 1 | 1993 | 61 | 0.010 |
Why?
|
| Cattle | 1 | 1993 | 375 | 0.010 |
Why?
|
| Protein Kinase C | 1 | 1993 | 268 | 0.010 |
Why?
|
| Reference Values | 1 | 1993 | 661 | 0.010 |
Why?
|
| Quality of Life | 1 | 2001 | 1668 | 0.010 |
Why?
|